November 15, 2011 (San Francisco, California) — A new treatment regimen with the low-molecular-weight heparin enoxaparin reduced the incidence of portal vein thrombosis (PVT), leading to fewer events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback